-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Eterna Therapeutics Inc. quarterly/annual Revenues history and growth rate from 2013 to 2023.
- Eterna Therapeutics Inc. Revenues for the quarter ending June 30, 2024 was $47K.
- Eterna Therapeutics Inc. annual Revenues for 2023 was $68K.
- Eterna Therapeutics Inc. annual Revenues for 2022 was $0.000.
- Eterna Therapeutics Inc. annual Revenues for 2020 was $5.8M, a 70.7% decline from 2019.